Clinical Trial Update: Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC [Phase 3]

View source ↗

Summary

Phase 3 trial assessing adjuvant entecavir or tenofovir after surgery for HBV-related hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Tenofovir (Tenofovir)

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED